SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-16-000116
Filing Date
2016-06-22
Accepted
2016-06-22 16:26:48
Documents
1
Period of Report
2016-06-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments

Document Format Files

Seq Description Document Type Size
1 8-K eb-8xkitem205xreductioninf.htm 8-K 32883
  Complete submission text file 0001485003-16-000116.txt   34009
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 161726833
SIC: 2834 Pharmaceutical Preparations